Predicting human immunodeficiency virus inhibitors using multi-dimensional Bayesian network classifiers
暂无分享,去创建一个
Concha Bielza | Pedro Larrañaga | Hanen Borchani | Carlos Toro | C. Bielza | P. Larrañaga | C. Toro | H. Borchani
[1] Saso Dzeroski,et al. An extensive experimental comparison of methods for multi-label learning , 2012, Pattern Recognit..
[2] Zhi-Hua Zhou,et al. ML-KNN: A lazy learning approach to multi-label learning , 2007, Pattern Recognit..
[3] Yves Moreau,et al. Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance , 2006, Bioinform..
[4] Bryan Chan,et al. Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database , 1999, Nucleic Acids Res..
[5] Judea Pearl,et al. Probabilistic reasoning in intelligent systems - networks of plausible inference , 1991, Morgan Kaufmann series in representation and reasoning.
[6] Zhi-Hua Zhou,et al. Multilabel Neural Networks with Applications to Functional Genomics and Text Categorization , 2006, IEEE Transactions on Knowledge and Data Engineering.
[7] Philippe Flandre,et al. Tipranavir-Ritonavir Genotypic Resistance Score in Protease Inhibitor-Experienced Patients , 2008, Antimicrobial Agents and Chemotherapy.
[8] D. Katzenstein,et al. Bayesian network analyses of resistance pathways against efavirenz and nevirapine , 2008, AIDS.
[9] Judea Pearl,et al. Equivalence and Synthesis of Causal Models , 1990, UAI.
[10] Constantin F. Aliferis,et al. HITON: A Novel Markov Blanket Algorithm for Optimal Variable Selection , 2003, AMIA.
[11] Thomas Lengauer,et al. Improved Prediction of Response to Antiretroviral Combination Therapy using the Genetic Barrier to Drug Resistance , 2006, Antiviral therapy.
[12] Constantin F. Aliferis,et al. Local Causal and Markov Blanket Induction for Causal Discovery and Feature Selection for Classification Part II: Analysis and Extensions , 2010, J. Mach. Learn. Res..
[13] Glenn Fung,et al. Automated Heart Wall Motion Abnormality Detection from Ultrasound Images Using Bayesian Networks , 2007, IJCAI.
[14] Luis Enrique Sucar,et al. A Two-Step Method to Learn Multidimensional Bayesian Network Classifiers Based on Mutual Information Measures , 2011, FLAIRS.
[15] S. Sarafianos,et al. Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition. , 2009, Journal of molecular biology.
[16] Philippe Flandre,et al. Factors Associated with the Selection of Mutations Conferring Resistance to Protease Inhibitors (PIs) in PI-Experienced Patients Displaying Treatment Failure on Darunavir , 2007, Antimicrobial Agents and Chemotherapy.
[17] Linda C. van der Gaag,et al. Inference and Learning in Multi-dimensional Bayesian Network Classifiers , 2007, ECSQARU.
[18] Judea Pearl,et al. The recovery of causal poly-trees from statistical data , 1987, Int. J. Approx. Reason..
[19] C. N. Liu,et al. Approximating discrete probability distributions with dependence trees , 1968, IEEE Trans. Inf. Theory.
[20] José Antonio Lozano,et al. Multi-Objective Learning of Multi-Dimensional Bayesian Classifiers , 2008, 2008 Eighth International Conference on Hybrid Intelligent Systems.
[21] P. Spirtes,et al. Causation, prediction, and search , 1993 .
[22] D. Richman,et al. 2022 update of the drug resistance mutations in HIV-1. , 2022, Topics in antiviral medicine.
[23] D. Rubin,et al. Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .
[24] T. Silander,et al. Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors. , 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[25] Colombe Chappey,et al. Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates. , 2003, The Journal of infectious diseases.
[26] Grigorios Tsoumakas,et al. Multi-Label Classification: An Overview , 2007, Int. J. Data Warehous. Min..
[27] Concha Bielza,et al. Multi-dimensional classification with Bayesian networks , 2011, Int. J. Approx. Reason..
[28] R. Shafer,et al. HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance , 2010, Antimicrobial Agents and Chemotherapy.
[29] D. Richman,et al. Update of the drug resistance mutations in HIV-1: December 2010. , 2010, Topics in HIV medicine : a publication of the International AIDS Society, USA.
[30] Wilhelm Huisinga,et al. Drug-Class Specific Impact of Antivirals on the Reproductive Capacity of HIV , 2010, PLoS Comput. Biol..
[31] Nir Friedman,et al. The Bayesian Structural EM Algorithm , 1998, UAI.
[32] Jason Weston,et al. A kernel method for multi-labelled classification , 2001, NIPS.
[33] Nir Friedman,et al. Probabilistic Graphical Models - Principles and Techniques , 2009 .
[34] P. Libin,et al. Resistance pathways of human immunodeficiency virus type 1 against the combination of zidovudine and lamivudine. , 2010, The Journal of general virology.
[35] Constantin F. Aliferis,et al. Local Causal and Markov Blanket Induction for Causal Discovery and Feature Selection for Classification Part I: Algorithms and Empirical Evaluation , 2010, J. Mach. Learn. Res..
[36] Concha Bielza,et al. Bayesian Chain Classifiers for Multidimensional Classification , 2011, IJCAI.
[37] Linda C. van der Gaag,et al. Multi-dimensional Bayesian Network Classifiers , 2006, Probabilistic Graphical Models.